Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
65.87
Dollar change
+0.50
Percentage change
0.76
%
IndexS&P 500 P/E19.99 EPS (ttm)3.29 Insider Own1.58% Shs Outstand224.29M Perf Week3.47%
Market Cap14.81B Forward P/E12.77 EPS next Y5.16 Insider Trans-0.83% Shs Float221.31M Perf Month7.21%
Income745.44M PEG0.86 EPS next Q0.93 Inst Own95.39% Short Float7.65% Perf Quarter24.71%
Sales3.77B P/S3.93 EPS this Y15.84% Inst Trans0.60% Short Ratio4.68 Perf Half Y7.67%
Book/sh24.02 P/B2.74 EPS next Y26.29% ROA11.53% Short Interest16.93M Perf Year4.72%
Cash/sh17.13 P/C3.85 EPS next 5Y23.13% ROE15.13% 52W Range50.27 - 67.36 Perf YTD4.91%
Dividend Est.- P/FCF18.73 EPS past 5Y38.99% ROI13.75% 52W High-2.22% Beta0.74
Dividend TTM- Quick Ratio3.43 Sales past 5Y14.55% Gross Margin91.46% 52W Low31.03% ATR (14)1.54
Dividend Ex-Date- Current Ratio3.47 EPS Y/Y TTM127.87% Oper. Margin18.91% RSI (14)69.92 Volatility2.34% 2.46%
Employees2524 Debt/Eq0.01 Sales Y/Y TTM8.58% Profit Margin19.78% Recom2.07 Target Price71.44
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q675.68% Payout0.00% Rel Volume0.42 Prev Close65.37
Sales Surprise-4.45% EPS Surprise-19.46% Sales Q/Q8.93% EarningsJul 30 BMO Avg Volume3.62M Price65.87
SMA206.63% SMA5010.74% SMA20013.64% Trades Volume1,513,874 Change0.76%
Date Action Analyst Rating Change Price Target Change
Jul-02-24Downgrade BMO Capital Markets Market Perform → Underperform $52 → $48
May-23-24Initiated Deutsche Bank Hold $55
Apr-23-24Initiated Cantor Fitzgerald Neutral
Feb-23-24Initiated Jefferies Buy $81
Feb-14-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-13-23Upgrade Leerink Partners Market Perform → Outperform $78
Dec-04-23Upgrade Guggenheim Neutral → Buy $86
Nov-21-23Downgrade Goldman Buy → Neutral $98 → $65
Jul-25-23Initiated Citigroup Buy $82
May-04-23Downgrade BofA Securities Buy → Neutral $84
Jul-15-24 07:00PM
02:01PM
Jul-09-24 05:08PM
08:00AM
06:53AM
06:00AM Loading…
06:00AM
Jul-08-24 04:30PM
Jul-05-24 06:20AM
Jul-02-24 05:27PM
Jul-01-24 02:18PM
Jun-14-24 03:00PM
Jun-13-24 08:00AM
Jun-11-24 08:00AM
Jun-07-24 04:30PM
May-30-24 04:05PM
11:31AM Loading…
11:31AM
May-21-24 01:15PM
08:00AM
May-17-24 12:24PM
May-14-24 05:00PM
03:18AM
May-13-24 05:24PM
05:23PM
01:49PM
12:41PM
10:57AM
09:24AM
09:14AM
08:24AM
07:00AM
08:26AM Loading…
May-12-24 08:26AM
May-10-24 03:17PM
May-09-24 06:15AM
May-02-24 11:17PM
08:00AM
May-01-24 11:24AM
11:12AM
10:53AM
10:33AM
10:20AM
08:55AM
07:58AM
07:50AM
Apr-30-24 04:31PM
02:57PM
11:54AM
11:50AM
10:10AM
09:36AM
09:30AM
08:34AM
07:10AM
07:00AM
Apr-23-24 10:12AM
10:01AM
09:44AM
07:00AM
Apr-15-24 05:30AM
Apr-11-24 08:00AM
Apr-06-24 08:56AM
Apr-01-24 08:30AM
08:30AM
Mar-31-24 11:53AM
Mar-29-24 04:30PM
Mar-26-24 02:47PM
Mar-17-24 08:50AM
Mar-15-24 10:37AM
Mar-14-24 11:30AM
08:18AM
Mar-12-24 01:52PM
Mar-11-24 01:02PM
07:18AM
Mar-10-24 04:05PM
04:05PM
Mar-07-24 03:00PM
Mar-04-24 08:00AM
Mar-03-24 08:29AM
Feb-29-24 10:19AM
07:30AM
Feb-28-24 01:10PM
Feb-27-24 04:08PM
Feb-26-24 03:20PM
Feb-21-24 04:50PM
Feb-15-24 08:00AM
Feb-14-24 09:32AM
01:15AM
12:12AM
Feb-13-24 05:43PM
11:37AM
09:30AM
08:26AM
08:25AM
07:38AM
07:35AM
07:34AM
07:00AM
Feb-09-24 11:03AM
09:15AM
Feb-07-24 08:55AM
Feb-06-24 04:30AM
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flannelly Barry PEVP & General Manager USJul 16 '24Sale64.191,30683,83258,042Jul 17 12:24 PM
Flannelly Barry PEVP & General Manager USJul 09 '24Sale60.008,148488,88050,534Jul 11 12:35 PM
Flannelly Barry PEVP & General Manager USJun 12 '24Sale60.0019,1641,149,84066,377Jun 14 12:17 PM
Tray ThomasPrincipal Accounting OfficerJun 06 '24Sale58.911,09364,38921,634Jun 10 12:25 PM
BAKER BROS. ADVISORS LPDirectorMay 07 '24Option Exercise49.0130,0001,470,30033,462,981May 09 06:25 PM
Stein Steven HEVP & Chief Medical OfficerJan 03 '24Sale65.517,365482,48190,218Jan 05 12:27 PM
Iyengar Vijay KEVP, GMAPPSJan 02 '24Sale65.0065742,70543,412Jan 04 01:05 PM
Tray ThomasPrincipal Accounting OfficerDec 13 '23Sale62.371,06766,54923,436Dec 14 02:11 PM
Tray ThomasPrincipal Accounting OfficerDec 12 '23Sale57.3621012,04624,503Dec 14 02:11 PM
SWAIN PAULA JEVP, Human ResourcesSep 01 '23Sale65.138,449550,28377,530Sep 06 04:00 PM
Stein Steven HEVP & Chief Medical OfficerAug 01 '23Sale63.2821,5111,361,21697,583Aug 03 04:00 PM